Page last updated: 2024-11-04

sulfasalazine and Infections, Legionella pneumophila

sulfasalazine has been researched along with Infections, Legionella pneumophila in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"After 2 weeks' treatment with sulfasalazine (SASP) and mesalazine enema, a 32-year-old female with recently diagnosed ulcerative colitis developed bilateral pulmonary infiltrates with peripheral eosinophilia."3.70[Sulfasalazine-induced pulmonary infiltrates and Legionella pneumonia]. ( Avar, S; Bielecki, JW; Joss, R, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bielecki, JW1
Avar, S1
Joss, R1

Other Studies

1 other study available for sulfasalazine and Infections, Legionella pneumophila

ArticleYear
[Sulfasalazine-induced pulmonary infiltrates and Legionella pneumonia].
    Schweizerische medizinische Wochenschrift, 2000, Jul-25, Volume: 130, Issue:29-30

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diagnosis, Differential; Enema;

2000